Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why it is still important that countries know the burden of pneumococcal disease.

× No keyword cloud information.

9 in total

1. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013.

Authors: Domenico Martinelli; Biagio Pedalino; Maria Giovanna Cappelli; Giovanni Caputi; Anna Sallustio; Francesca Fortunato; Silvio Tafuri; Vanessa Cozza; Cinzia Germinario; Maria Chironna; Rosa Prato
Journal: Hum Vaccin Immunother Date: 2013-10-07 Impact factor: 3.452

2. Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies.

Authors: Emanuele Amodio; Claudio Costantino; Sara Boccalini; Fabio Tramuto; Carmelo M Maida; Francesco Vitale
Journal: Hum Vaccin Immunother Date: 2014-02-27 Impact factor: 3.452

3. An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign.

Authors: Donatella Panatto; Alexander Domnich; Roberto Gasparini; Paolo Bonanni; Giancarlo Icardi; Daniela Amicizia; Lucia Arata; Stefano Carozzo; Alessio Signori; Angela Bechini; Sara Boccalini
Journal: J Med Internet Res Date: 2016-12-02 Impact factor: 5.428

4. Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?

Authors: Sara Boccalini; Ornella Varone; Martina Chellini; Luca Pieri; Antonino Sala; Cesare Berardi; Paolo Bonanni; Angela Bechini
Journal: Hum Vaccin Immunother Date: 2016-12-07 Impact factor: 3.452

5. Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012.

Authors: Jana Yr Lai; Heather Cook; Teem-Wing Yip; Jeanette Berthelsen; Stephen Gourley; Vicki Krause; Helen Smith; Amanda J Leach; Heidi Smith-Vaughan
Journal: BMC Infect Dis Date: 2013-09-03 Impact factor: 3.090

6. Knowledge of serotype prevalence & burden of invasive pneumococcal disease: A prerequisite to vaccine introduction in the country.

Authors: Reba Kanungo
Journal: Indian J Med Res Date: 2015-09 Impact factor: 2.375

7. A comparative public health and budget impact analysis of pneumococcal vaccines: The French case.

Authors: Yiling Jiang; Frédéric Gervais; Aline Gauthier; Charles Baptiste; Prescilla Martinon; Xavier Bresse
Journal: Hum Vaccin Immunother Date: 2015-08-12 Impact factor: 3.452

8. Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain.

Authors: Jose Miguel Rodríguez González-Moro; Rosario Menéndez; Magda Campins; Nadia Lwoff; Itziar Oyagüez; María Echave; Javier Rejas; Fernando Antoñanzas
Journal: Clin Drug Investig Date: 2016-01 Impact factor: 2.859

9. Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports.

Authors: Hamid Latifi-Navid; Saeid Latifi-Navid; Behdad Mostafaiy; Sadegh Azimzadeh Jamalkandi; Ali Ahmadi
Journal: Sci Rep Date: 2018-07-23 Impact factor: 4.379

9 in total